BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification | MarketScreener
TEL AVIV, Israel, Nov. 4, 2022 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a pre-commercial-stage biopharmaceutical company ...
Read moreTEL AVIV, Israel, Nov. 4, 2022 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a pre-commercial-stage biopharmaceutical company ...
Read more© 2022 TheDailyStock.News